Cannabinoid Invest Information

SciSparc Ltd. Signs Exclusive License Agreement with Polyrizon for Cannabinoid-Based Pain Therapy Aug 20, 2024

SciSparc Ltd. Embarks on Transformative Phase IIb Trial for Tourette Syndrome Using THC-Based Medication Nov 11, 2023